Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for ...
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...
Glenmark Pharma Share Price News: Mumbai-headquartered pharmaceuticals company Glenmark Pharma's shares are in the spotlight once again on Dalal Street.The company's US arm has released its injection ...
Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results